Unit of Cardiovascular Science, Campus Bio-Medico University, Rome, Italy.
Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Catholic University of the Sacred Heart, Rome, Italy.
Prog Cardiovasc Dis. 2020 May-Jun;63(3):233-242. doi: 10.1016/j.pcad.2020.02.009. Epub 2020 Feb 13.
Endothelial dysfunction (EnD) is a hallmark feature of coronary artery disease (CAD), representing the key early step of atherosclerotic plaque development and progression. Percutaneous coronary intervention (PCI) is performed daily worldwide to treat symptomatic CAD, however a consistent proportion of patients remain symptomatic for angina despite otherwise successful revascularization. EnD plays a central role in the mechanisms of post-PCI angina, as it is strictly associated with both structural and functional abnormalities in the coronary arteries that may persist, or even accentuate, following PCI. The assessment of endothelial function in patients undergoing PCI might help to identify those patients at higher risk of future cardiovascular events and recurrent/persistent angina who might therefore benefit more from an intensive treatment. In this review, we address the role of EnD in determining angina after PCI, discussing its pathophysiological mechanisms, diagnostic approaches and therapeutic perspectives.
内皮功能障碍(Endothelial dysfunction,EnD)是冠状动脉疾病(Coronary artery disease,CAD)的一个显著特征,代表了动脉粥样硬化斑块发展和进展的关键早期步骤。全球范围内每天都进行经皮冠状动脉介入治疗(Percutaneous coronary intervention,PCI)来治疗有症状的 CAD,然而,尽管血运重建成功,仍有相当一部分患者持续存在心绞痛症状。EnD 在 PCI 后心绞痛的发病机制中起着核心作用,因为它与 PCI 后可能持续存在甚至加重的冠状动脉结构和功能异常密切相关。对接受 PCI 的患者进行内皮功能评估可能有助于识别那些未来心血管事件和复发性/持续性心绞痛风险较高的患者,这些患者可能因此从强化治疗中获益更多。在这篇综述中,我们探讨了 EnD 在 PCI 后心绞痛中的作用,讨论了其病理生理机制、诊断方法和治疗前景。